The role of apoptotic cell death in the radiosensitising effect of gemcitabine

被引:16
作者
Pauwels, B. [1 ]
Vermorken, J. B. [1 ]
Wouters, A. [1 ]
Ides, J. [1 ]
Van Laere, S. [2 ]
Lambrechts, H. A. J. [1 ]
Pattyn, G. G. O. [1 ]
Vermeulen, K. [3 ]
Meijnders, P. [4 ]
Lardon, F. [1 ]
机构
[1] Univ Antwerp, Lab Canc Res & Clin Oncol, B-2610 Antwerp, Belgium
[2] Univ Antwerp, Pathol Lab, Translat Canc Res Grp, B-2610 Antwerp, Belgium
[3] Univ Antwerp, Lab Expt Hematol, B-2650 Edegem, Belgium
[4] Univ Radiotherapy, ZNA Middelheim, B-2020 Antwerp, Belgium
关键词
gemcitabine; radiation; radiosensitisation; cell cycle; apoptosis; PANCREATIC-CANCER CELLS; DRUG-INDUCED APOPTOSIS; IN-VITRO; MEDIATED APOPTOSIS; MECHANISM; LINES; RADIATION; PATHWAY; CHEMOTHERAPY; VINORELBINE;
D O I
10.1038/sj.bjc.6605145
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: The aim of this study was to evaluate the radiosensitising effect of gemcitabine, in terms of cell-cycle progression, induction of apoptosis, and to investigate the molecular events regulating apoptosis. METHODS: Tumour cells were treated with gemcitabine, radiation, or the combination. 0-72 h after treatment, cells were collected for cell-cycle analysis and apoptosis determination. Caspase 8 and 9, Bid and tBid expression were determined by western blot. The mitochondrial membrane potential was determined using flow cytometry. An RT2 Profiler PCR Array for human apoptotic genes was performed after the combination or TRAIL treatment. RESULTS: Gemcitabine and radiation resulted in an early S-phase block immediately after treatment, after which the cells moved synchronously through the cell cycle. When cell-cycle distribution returned to pre-treatment levels, an increased induction of apoptosis was observed with activation of caspase 8 and 9 and a reduction of the mitochondrial membrane potential. Gene expression after treatment with radiosensitising conditions was comparable with expression after the TRAIL treatment. CONCLUSION: A role for the cell-cycle perturbations and the induction of apoptosis could be attributed to the radiosensitising effect of gemcitabine. Apoptosis induction was comparable with the apoptotic pathway observed after the TRAIL treatment, that is the involvement of the extrinsic apoptosis pathway. British Journal of Cancer (2009) 101, 628-636. doi: 10.1038/sj.bjc.6605145 www.bjcancer.com (C) 2009 Cancer Research UK
引用
收藏
页码:628 / 636
页数:9
相关论文
共 47 条
[1]   Reasons to reconsider the significance of apoptosis for cancer therapy [J].
Abend, M .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2003, 79 (12) :927-941
[2]   Apoptosis: mediator or mode of cell killing by anticancer agents? [J].
Brown, JM ;
Wouters, BG .
DRUG RESISTANCE UPDATES, 2001, 4 (02) :135-136
[3]   Apoptosis genes and resistance to cancer therapy - What do the experimental and clinical data tell us? [J].
Brown, M ;
Wilson, G .
CANCER BIOLOGY & THERAPY, 2003, 2 (05) :477-490
[4]   Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway [J].
Chang, GC ;
Hsu, SL ;
Tsai, JR ;
Wu, WJ ;
Chen, CY ;
Sheu, GT .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 502 (03) :169-183
[5]   Gemcitabine-mediated apoptosis is associated with increased CD95 surface expression but is not inhibited by DN-FADD in Colo357 pancreatic cancer cells [J].
Christgen, M ;
Schniewind, B ;
Jueschke, A ;
Ungefroren, H ;
Kalthoff, H .
CANCER LETTERS, 2005, 227 (02) :193-200
[6]  
Creane M, 1999, INT J RADIAT BIOL, V75, P731, DOI 10.1080/095530099140078
[7]   Death receptors in chemotherapy and cancer [J].
Debatin, KM ;
Krammer, PH .
ONCOGENE, 2004, 23 (16) :2950-2966
[8]  
Doyle TH, 2001, CLIN CANCER RES, V7, P226
[9]  
Ferreira CG, 2000, CANCER RES, V60, P7133
[10]  
Ferreira CG, 2000, CLIN CANCER RES, V6, P203